Product Visual Guide

Similar documents
ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER

Commissioning policies agreed by PCTs in Yorkshire and the Humber at Board meeting of YH SCG on December

Title Cancer Drug Phase Status

National Cancer Drugs Fund List - Approved

Docetaxel. Class: Antineoplastic agent, Antimicrotubular, Taxane derivative.

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.

MEDICAL PRIOR AUTHORIZATION

Active Cancer Studies by Approval Date For additional information on any one of these studies contact the Lancaster General Cancer Center

Azacitidine Vidaza Non-transplant myelodysplastic syndrome Funded Funded Funded Funded Funded Funded Not Funded

Avastin (bevacizumab) DRUG.00028, CG-DRUG-68

CancerPACT Cancer Patients Alliance for Clinical Trials

H&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS

Index. Note: Page numbers of article titles are in boldface type.

NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Friday, 1 May 2009 SUMMARY REPORT

NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Fall Conference Call 23 November 2009 SUMMARY REPORT

SUPPLEMENTARY INFORMATION

For Health Professionals Who Care For Cancer Patients

CLINICAL TRIALS ACC. Jul 2016

Open and Pending Trials Listing For Arizona Oncology Associates P.C. HOPE Division/ Tucson, Arizona

National Horizon Scanning Centre. Sunitinib (Sutent) for advanced and/or metastatic breast cancer. December 2007

Avastin Sample Coding

Keytruda (pembrolizumab)

London Cancer New Drugs Group. February London Cancer New Drugs Group (LCNDG) Work Plan for the London Cancer Drugs Fund list.

through the cell cycle. However, how we administer drugs also depends on the combinations that we give and the doses that we give.

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting


Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

World Health Organization: Essential Medicines and Devices for Cancer:

An D. Nguyen, MD Curriculum Vitae

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List

For Health Professionals Who Care For Cancer Patients

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)

Guideline Update on Antiemetics

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

The Clinical Research E-News

The Royal Marsden NHS Foundation Trust Medicines Formulary. NICE register for medicines initiated at the trust. Type and code. Publication.

WASHINGTON. Spokane Cheney. Olympia. Tri-Cities. Walla Walla. Portland North Central Oregon City OREGON. Mt. Vernon. Port Angeles

For Health Professionals Who Care For Cancer Patients EDITOR S CHOICE

Working Formulary January 2013 Oncology Chemotherapy Regimens

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of )

Medical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia

Summary of Research and Writing Activities in Oncology

CancerPACTS. Cancer Patients Alliance for Clinical Trials and Survivorship

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!

The Clinical Research E-News

Avastin. Avastin (bevacizumab) Description

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation) 3. Antimetabolites (anti-folates, pyrimidine and purine analogues)

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

University of Groningen. Health economics of targeted cancer therapies Mihajlovic, Jovan

The legally binding text is the original French version

Clinical Policy: Cetuximab (Erbitux) Reference Number: PA.CP.PHAR.317

Avastin (bevacizumab)

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS

CCC Chemotherapy Protocols V9.0

Lipoplatin monotherapy for oncologists

Pharmacy Prior Authorization Colony Stimulating Factor (CSF)/Myeloid Growth Factor (MGF) Clinical Guideline

FULL PRESCRIBING INFORMATION: CONTENTS*

MASCC Guidelines for Antiemetic control: An update

General Authorization Criteria for ALL Agents and Indications:

Management of advanced non small cell lung cancer

Drugs approved from 1st January 2015 till present. S.NO Name Of Drug Indication Date of Approval 1 Levocetirizine ODS 2.5mg /5mg (Additional

Haematology, Oncology and Palliative Care Directorate.

Guidelines for the Use of Anti-Emetics with Chemotherapy

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,

Essentials. Oncology Practise Essentials. Oncology Basics. Tutorial 2. Cancer Chemotherapy

CancerPACT Cancer Patients Alliance for Clinical Trials

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

Macmillan Publications

Cancer drug approvals for paediatric indications (n=43)

Cytochrome P450 3A4 inducers, inhibitors, or substrates: May alter (2.1)

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY)

CASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES

The Clinical Research E-News

Elements for a Public Summary

American Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG.

Policy. ( Number: *Pleasesee amendment forpennsylvaniamedicaidatthe endofthis CPB.

Annual Flash Report (unaudited) Fiscal Year ended March 31, 2017

Clinical Policy: Pemetrexed (Alimta) Reference Number: CP.PHAR.368 Effective Date: Last Review Date: Line of Business: Medicaid

See Important Reminder at the end of this policy for important regulatory and legal information.

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List

Open Trials as of end of March 2016

Horizon Scanning Centre November Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer first line

Avastin. Avastin (bevacizumab) Description

Chemotherapy Treatment Algorithms for Urology Cancer

Advances in Chemotherapy for Non-Small Cell Lung Cancer

Disease Site Sub-Disease Site Intent Regimen Code Regimen Details Status (as of October 17, 2017) Breast Not Applicable Adjuvant / Curative

Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium

CLINICAL MEDICAL POLICY

OPEN TRIALS Accruals counted until 30-April Current Accrual

The Clinical Research E-News

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information.

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

Erbitux. Erbitux (cetuximab) Description

DOSAGE FORMS AND STRENGTHS One vial docetaxel: Single use vials 20 mg/ml, 80 mg/4 ml and 160 mg/8 ml (3)

It is a malignancy originating from breast tissue

Transcription:

Product Visual Guide

Teamwork A team with an unflinching faith in one another is one of our core strength. Excellence Achieving excellence is not the end result, we begin with excelling in any endeavor. Accountability To be answerable is one of the keys to achieve the trust and respect from our customers. Righteousness and truthfulness are at the core of our work philosophy. Integrity OUR VALUES Standing on these four pillars, our company aims to be the most trusted company among healthcare professional and institutions in cancer care.

PRODUCTS FOR SOLID TUMORS I-DOX (Doxorubicin Hydrochloride Liposome Injection) As Pegylated Liposome 20mg/10ml 50mg/25ml Store between 2-8 C (36-46 F) in a refrigerator. Do not freeze. Metastatic Carcinoma of the Ovary whose disease has progressed or recurred after platinum-based chemotherapy Metastatic Breast Cancer patients with increased cardiac risk In combination with bortezomib for patients with Multiple Myeloma TAXE-RTU (Docetaxel Injection) One Vial Formulation 20mg/ml 80mg/4ml 120mg/6ml Store at a temperature not exceeding 25 C (77 F). Protect from light. Hormone Refractory Prostate Cancer (HRPC) Metastatic Breast Cancer NSCLC TAXEWELL (Docetaxel Injection Concentrate with Solvent) 20mg / 0.5ml 80mg / 2ml 120mg / 3ml Single use vial Single use vial Single use vial + Solvent in a combipack Store under refrigeration between 2-8 C (36-46 F). Protect from light. Hormone Refractory Prostate Cancer (HRPC) Metastatic Breast Cancer NSCLC 1

PRODUCTS FOR SOLID TUMORS PACLIWEL (Paclitaxel Injection) 30mg / 5ml 100mg / 16.7ml 260mg / 43.4ml 300mg / 50ml Multi Dose Vial Multi Dose Vial Multi Dose Vial Multi Dose Vial Store between 20-25 C (68-77 F). Protect from light. Retain in carton until use. For the treatment of advanced carcinoma of the ovary For the adjuvant treatment of node-positive breast cancer GEFTIWEL (Gefitinib Tablets) 250mg Beige coloured, capsule shape film coated tablets 3x10 Tablets Store below 30 C (86 F). Protect from light and moisture. For locally advanced or metastatic NSCLC PEMETRA (Pemetrexed for Injection) 100mg 500 mg Store between 20-25 C (68-77 F); Excursions permitted from 15-30 C (59-86 F). For advanced nonsquamous non-small cell lung cancer (NSCLC), after prior chemotherapy In malignant pleural mesothelioma along with cisplatin, when surgery is not an option 2

PRODUCTS FOR SOLID TUMORS GEMWEL (Gemcitabine for Injection) 200mg 1gm Store between 20-25 C (68-77 F); Excursions permitted from 15-30 C (59-86 F). In relapsed advanced ovarian cancer in combination with Carboplatin In metastatic breast cancer patients after failure of prior anthracycline containing adjuvant therapy For inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer In locally advanced or metastatic Adenocarcinoma of the pancreas CISWEL (Cisplatin Injection) 10mg/10ml 50mg/50ml Store between 15-25 C (59-77 F). Protect from light. Do not freeze. For metastatic testicular tumors, ovarian tumors & bladder cancer TEMZOL (Temozolomide Capsules) 20mg 100mg 250mg Yellow coloured hard gelatin capsules Sky Blue coloured hard gelatin capsules White coloured hard gelatin capsules 1x5 Capsules 1x5 Capsules 1x5 Capsules Store between 20-25 C (68-77 F). Protect from light and moisture. In newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and then as a maintenance treatment In Refractory anaplastic astrocytomas 3

PRODUCTS FOR SOLID TUMORS TEMZOL (Temozolomide for Injection) 100mg Store under refrigeration between 2-8 C (36-46 F). Do not freeze. In newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and then as maintenance treatment In Refractory anaplastic astrocytomas RINOWEL (Irinotecan Hydrochloride Injection) 40mg/2ml 100mg/5ml Store between 20-25 C (68-77 F). Protect from light. Retain in carton until use. In Metastatic Carcinoma of Colon & Rectum with 5-Fluorouracil and Leucovorin XYLOTIN (Oxaliplatin Injection) 50mg/25ml 100mg/50ml Store between 20-25 C (68-77 F). Protect from light. Retain in carton until use. As an adjuvant treatment of stage III (Duke's C) colon cancer in patients who have undergone complete resection of the primary tumor In the treatment of advanced metastatic colorectal cancer 4

PRODUCTS FOR SOLID TUMORS EPIRUBA (Epirubicin Hydrochloride for Injection ) 10mg 50mg Store at controlled room temperature 15-30 C (59-86 F). Protect from light. As a adjuvant therapy in patients with evidence of axillary node tumor involvement in primary breast cancer DOXORUBA (Doxorubicin HCl Injection) 10mg/5ml 50mg/25ml Store under refrigeration between 2-8 C (36-46 F). Protect from light. Carcinoma of the breast, lung, bladder, thyroid and also ovarian cancer Hodgkin's lymphoma and Non Hodgkin's lymphoma DOXORUBA (Doxorubicin Injection) 10mg 50mg Store between 15-30 C (59-86 F). Protect from light. Carcinoma of the breast, lung, bladder, thyroid and also ovarian cancer Hodgkin's lymphoma and Non Hodgkin's lymphoma 5

PRODUCTS FOR SOLID TUMORS CABITA (Capecitabine Tablets) 500mg Beige coloured, capsule shaped film coated tablets 1 x10 Capsules Store below 30 C (86 F). Protect from light and moisture. Treatment of Adjuvant Colorectal Cancer and Metastatic Breast Cancer FOSFA (Ifosfamide for Injection with Mesna Injection) 1gm 2gm 3gm Store below 25 C (77 F). Avoid extended exposure to temperature above 30 C (86 F). In Soft tissue sarcoma In advanced or recurrent cervical carcinoma Mesna Injection Strengths - 2ml, 4ml (Store in a cool and dark place) As a prophylatic agent in reducing the incidence of ifosfamide induced hemorrhagic cystitis ETOPA (Etoposide Capsules) 50mg 100mg Yellow coloured hard gelatin capsules Yellow coloured hard gelatin capsules 1x8 Capsules 1x8 Capsules Store below 25 C (77 F). Protect from light and moisture. Small cell lung cancer Testicular cancer Bladder cancer Hodgkin's lymphoma Non-Hodgkin's lymphoma 6

PRODUCTS FOR SOLID TUMORS ETOPA (Etoposide Injection) 100mg/5ml Store between 20-25 C (68-77 F). Protect from light. Do not freeze. Small cell lung cancer Testicular cancer Bladder cancer Hodgkin's lymphoma Non-Hodgkin's lymphoma CYPHOS (Cyclophosphamide Injection) 200mg 500mg 1gm Store below 25 C (77 F). Avoid extended exposure to temperature above 30 C (86 F) Hodgkin's lymphoma, Lymphocytic lymphoma, Mixed cell type lymphoma, Histocytic lymphoma Multiple Myeloma Leukemias Carcinoma of breast TINOWEL (Dactinomycin for Injection) 0.5 mg Store between 20-25 C (68-77 F). Protect from light. Wilm's tumor, childhood rhabdomyosarcoma, Ewing's Sarcoma and metastatic non-seminomatous testicular cancer For Palliative or adjunctive treatment of locally recurrent or locoregional solid malignancies 7

PRODUCTS FOR SOLID TUMORS CARBOWEL (Carboplatin Injection) 150mg/15ml 450mg/45ml Store between 20-25 C (68-77 F). Protect from light. Do not freeze. For ovarian carcinoma in combination with Cyclophosphamide For the palliative treatment of patients with recurrent ovarian carcinoma 8

PRODUCTS FOR HEMATOLOGICAL MALIGNANCIES NEOMIB (Bor tezomib for Injection) 2mg 3.5 mg Store between 20-25 C (68-77 F). Protect from light. Multiple Myeloma Mantle Cell Lymphoma who have received at least 1 prior therapy AZACITE (Azacitidine For Injection) 100mg Store between 20-25 C (68-77 F); Excursion permitted from 15-30 C (59-86 F). Used for treatment of French American British(FAB) myelodysplastic syndrome subtypes:refractory anemia(ra)or refractory anemia with ringed sideroblasts, refractory anemia with excess blasts(raeb), refractory anemia with excess blasts in transformation(raeb-t) and chronic myelomonocytic leukemia(cmmol) DECIMA (Decitabine Powder For Injection) 50mg Store between 20-25 C (68-77 F); Excursion permitted from 15-30 C (59-86 F). For the treatment of patients with Myelodysplastic syndrome (MDS) including previously treated and untreated, de novo and secondary MDS For the treatment of Acute Myeloid Leukemia (AML) 9

PRODUCTS FOR HEMATOLOGICAL MALIGNANCIES BLEOWEL (Bleomycin for Injection) 15 Units Store under refrigeration between 2-8 C (36-46 F). Squamous cell carcinoma Hodgkin s and non-hodgkin s Lymphoma Testicular carcinoma Malignant Pleural Effusion B E N D AW E L (Bendamustine Hydrochloride for Injection) 100mg Stored between 20-25 C (68-77 F); Excursions permitted from 15-30 C (59-86 F). Protect from light. In chronic lymphocytic leukemia In indolent B-cell non-hodgkin s lymphoma that has progressed during or within six months of treatment with rituximab MATNIB (Imatinib Mesylate Tablets) 100mg 400mg Brick Red coloured, capsule shape film coated tablets Beige coloured, capsule shape film coated tablets 1x10 Tablets 1x10 Tablets Store below 30 C (86 F). Protect from light and moisture. In Philadelphia chromosome positive myeloid leukemia For the treatment of Gastrointestinal Stromal Tumors (GIST) 10

PRODUCTS FOR HEMATOLOGICAL MALIGNANCIES L-GINASE (L-Asparaginase for Injection) 5000 I.U. 10000 I.U. Store betwe en 2-8 C (36-46 F). Discard reconstituted solution wi thin 8 hours. As a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) THALIMIDE (Thalidomide Capsules) 50mg 100mg Light green coloured hard gelatin capsules Dark blue coloured hard gelatin capsules 3x10 Capsules 3x10 Capsules Store below 25 C (77 F). Protect from Light and moisture. Cutaneous manifestations of moderate to severe Erythema Nodosum Leprosum (ENL) Patients with newly diagnosed Multiple Myeloma in combination with Dexamethasone 11

PRODUCTS FOR SUPPORTIVE CARE ZOLDRON (Zoledronic Acid for Injection) 4mg Store between 20-25 C (68-77 F). Protect from light. In hypercalcemia of malignancy For bone metastasis in patients with multiple myeloma and solid tumors LEUCOWEL (Leucovorin Calcium Injection) 15mg/2ml 50mg/5ml Store between 2-8 C (36-46 F). Do not freeze. Protect from light. After high dose Methotrexate therapy in osteosarcoma to diminish the toxicity caused by Methotrexate For use in combination with 5-fluorouracil to prolong survival in the palliative treatment patients with advanced colorectal cancer MEGETRA (Megestrol Acetate Tablets) 40 mg 160 mg White coloured, round, flat uncoated tablets White coloured, round, flat uncoated tablets 1 X 10 Tablets 1 X 10 Tablets Store below 25 C (77 F). Protect from light and moisture. In palliative treatment of advanced carcinomas especially for Anorexia Cachexia Syndrome 12

PRODUCTS FOR SUPPORTIVE CARE ULACTA (Urea & Lactic Acid Cream) Composition DESCRIPTION PACK SIZE Urea 12.0% w/w White coloured cream 75 gm Lactic acid 6.0% w/w in a round shaped jar Excipients q.s. Store below 25 C (77 F). Protect from light. For treating Hand and Foot Syndrome caused by various anti-cancer drugs Used for correction of hyperkeratosis and dryness in ichthyosis and allied conditions characterised by dry, rough, scaly skin GLUTAM -15 (L-Glutamine Oral Powder) Composition DESCRIPTION PACK SIZE L-Glutamine 10gm Fine graded Powder 5 Sachets x 15 gms Orange Flavour Excipients q.s. Store below 25 C (77 F). Protect from light and moisture. Decreases the incidence and severity of adverse effects due to radiation and chemotherapy in cancer patients such as: dermatitis, Stomatitis, Oesophagitis, intestinal permeability, Diarrhea DEXAM (Dexamethasone Tablets) 4mg 8mg Round white biconvex uncoated tablets Round white biconvex uncoated tablets 5x8 Tablets 5x8 Tablets Store below 25 C (77 F). Protect from light and moisture. For palliative management of Leukemias and Lymphomas in adults and acute leukemias of childhood As premedication in chemotherapy associated nausea and vomiting and taxane therapy 13

Getwell Group of Companies Getwell Pharmaceuticals Getwell Oncology Pvt. Ltd. Manufacturing Facility: 474, Udyog Vihar, Phase-V, Gurgaon-122 016, Haryana. INDIA Phone: +91-124-4014 403/04 www.getwelloncology.com Corporate Office: 464, Udyog Vihar, Phase-V, Gurgaon-122 016, Haryana. INDIA Phone: +91-124-4477 981/82 www.getwelloncology.com